✦ LIBER ✦

A Phase I Study of Pegylated Liposomal Doxorubicin and Irinotecan in Patients with Solid Tumors

✍ Scribed by Morgensztern, Daniel; Baggstrom, Maria Q.; Pillot, Giancarlo; Tan, Benjamin; Fracasso, Paula; Suresh, Rama; Wildi, Jonathan; Govindan, Ramaswamy

Book ID: 120558434
Publisher: S. Karger AG
Year: 2009
Tongue: English
Weight: 133 KB
Volume: 55
Category: Article
ISSN: 0009-3157
DOI: 10.1159/000264925

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I and pharmacokinetic study of IHL

Phase I and pharmacokinetic study of IHL-305 (PEGylated liposomal irinotecan) in patients with advanced solid tumors

✍ Jeffrey R. Infante, Vicki L. Keedy… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 333 KB

A phase I study of pegylated liposomal d

A phase I study of pegylated liposomal doxorubicin and temsirolimus in patients with refractory solid malignancies

✍ Wang-Gillam, Andrea; Thakkar, Nilay; Lockhart, A. Craig; Williams, Kerry; Baggst 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 282 KB

A phase I and pharmacologic study of the

A phase I and pharmacologic study of the combination of bortezomib and pegylated liposomal doxorubicin in patients with refractory solid tumors

✍ E. Claire Dees; Bert H. O’Neil; Celeste M. Lindley; Frances Collichio; Lisa A. C 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 527 KB

Phase I study of pegylated liposomal dox

Phase I study of pegylated liposomal doxorubicin and gemcitabine in patients with advanced malignancies

✍ Paula M. Fracasso; Kristie A. Blum; Benjamin R. Tan; Carole L. Fears; Nancy L. B 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views

## Abstract ## BACKGROUND Pegylated liposomal doxorubicin (PEG‐LD) and gemcitabine have single‐agent activity in breast and ovarian carcinoma patients. We conducted a Phase I trial to evaluate the maximum tolerated dose (MTD) and toxicities of this combination in patients with advanced malignancie

Phase I study of liposomal doxorubicin (

Phase I study of liposomal doxorubicin (Doxil) and cyclophosphamide in solid tumors

✍ Basil F. El-Rayes; Dina Ibrahim; Anthony F. Shields; Patricia M. LoRusso; Mark M 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 59 KB

A phase I study of irinotecan and pegyla

A phase I study of irinotecan and pegylated liposomal doxorubicin in recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study)

✍ Shoji, Tadahiro; Takatori, Eriko; Kaido, Yoshitaka; Omi, Hideo; Yokoyama, Yoshih 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 201 KB